03 Profile
Hansard to 12 November 2026 · 31,484 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Diabetes
Erik Huneker
co-founder and chief science officer of Diabeloop
Quoted in the press, across 1 topic since 19 Feb 2026
02 Quoted on · 1 of 29 topics
Erik Huneker: key facts
- Kind of voice
- Sector leader
- Role
- co-founder and chief science officer of Diabeloop
- Quoted on
- Diabetes
- Press coverage
- Quoted in the press
- Most recently quoted
- 19 Feb 2026
04 On the record · press
What Erik Huneker has said
- pmlive.com
Where Erik Huneker has been quoted
- Diabeloop’s DBLG2 receives FDA and CE clearance for automated insulin delivery without meal inputpmlive.com · 19 Feb 2026
How we found the articles that name Erik Huneker: we searched news for these terms.
- diabetes
- type 1 diabetes
- type 2 diabetes
- insulin
- diabetic
- diabetes prevention
Also searched with “diabetes” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Diabetes
Verbatim
“Reducing the need for meal-time interventions has been a longstanding goal for automated insulin delivery systems. DBLG2's ability to adapt in real-time and correct glycaemic excursions even without manual meal input offers patients flexibility in managing their diabetes.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.